Grantham, Mayo, Van Otterloo & Co (GMO)’s Ameriprise Financial AMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.07M | Buy |
2,419
+10
| +0.4% | +$4.82K | ﹤0.01% | 499 |
|
|
2025
Q4 | $1.18M | Buy |
+2,409
| New | +$1.14M | ﹤0.01% | 489 |
|
|
2025
Q2 | – | Sell |
-1,200
| Closed | -$581K | – | 612 |
|
|
2025
Q1 | $581K | Buy |
+1,200
| New | +$629K | ﹤0.01% | 532 |
|
|
2023
Q3 | – | Sell |
-5,475
| Closed | -$1.82M | – | 577 |
|
|
2023
Q2 | $1.82M | Sell |
5,475
-6,004
| -52% | -$1.85M | 0.01% | 449 |
|
|
2023
Q1 | $3.52M | Sell |
11,479
-4,000
| -26% | -$1.31M | 0.02% | 366 |
|
|
2022
Q4 | $4.82M | Sell |
15,479
-5,100
| -25% | -$1.56M | 0.03% | 340 |
|
|
2022
Q3 | $5.18M | Sell |
20,579
-17,000
| -45% | -$4.47M | 0.03% | 326 |
|
|
2022
Q2 | $8.93M | Buy |
37,579
+9,067
| +32% | +$2.43M | 0.05% | 267 |
|
|
2022
Q1 | $8.56M | Buy |
28,512
+24,690
| +646% | +$7.47M | 0.04% | 285 |
|
|
2021
Q4 | $1.15M | Sell |
3,822
-17
| -0.4% | -$5.03K | 0.01% | 526 |
|
|
2021
Q3 | $1.01M | Buy |
3,839
+1,100
| +40% | +$288K | 0.01% | 527 |
|
|
2021
Q2 | $682K | Buy |
2,739
+1,051
| +62% | +$265K | ﹤0.01% | 578 |
|
|
2021
Q1 | $392K | Sell |
1,688
-8,600
| -84% | -$1.86M | ﹤0.01% | 738 |
|
|
2020
Q4 | $2M | Sell |
10,288
-6,500
| -39% | -$1.16M | 0.01% | 441 |
|
|
2020
Q3 | $2.59M | Sell |
16,788
-5,900
| -26% | -$909K | 0.02% | 362 |
|
|
2020
Q2 | $3.4M | Sell |
22,688
-13,097
| -37% | -$1.68M | 0.03% | 316 |
|
|
2020
Q1 | $3.67M | Sell |
35,785
-2,266
| -6% | -$336K | 0.03% | 285 |
|
|
2019
Q4 | $6.34M | Sell |
38,051
-12,163
| -24% | -$1.88M | 0.04% | 257 |
|
|
2019
Q3 | $7.39M | Sell |
50,214
-15,600
| -24% | -$2.19M | 0.05% | 227 |
|
|
2019
Q2 | $9.55M | Sell |
65,814
-9,400
| -12% | -$1.36M | 0.07% | 195 |
|
|
2019
Q1 | $9.63M | Sell |
75,214
-600
| -0.8% | -$74.5K | 0.07% | 184 |
|
|
2018
Q4 | $7.91M | Sell |
75,814
-5,100
| -6% | -$640K | 0.06% | 156 |
|
|
2018
Q3 | $11.9M | Sell |
80,914
-36,100
| -31% | -$5.17M | 0.08% | 142 |
|
|
2018
Q2 | $16.4M | Sell |
117,014
-36,286
| -24% | -$5.14M | 0.12% | 118 |
|
|
2018
Q1 | $22.7M | Sell |
153,300
-1,400
| -0.9% | -$228K | 0.14% | 98 |
|
|
2017
Q4 | $26.2M | Buy |
154,700
+40,900
| +36% | +$6.55M | 0.15% | 94 |
|
|
2017
Q3 | $16.9M | Buy |
+113,800
| New | +$15.9M | 0.1% | 123 |
|
|
2015
Q4 | – | Sell |
-14,025
| Closed | -$1.53M | – | 550 |
|
|
2015
Q3 | $1.53M | Sell |
14,025
-27,175
| -66% | -$3.21M | 0.01% | 357 |
|
|
2015
Q2 | $5.15M | Sell |
41,200
-9,600
| -19% | -$1.22M | 0.02% | 249 |
|
|
2015
Q1 | $6.65M | Buy |
50,800
+3,100
| +6% | +$408K | 0.02% | 235 |
|
|
2014
Q4 | $6.31M | Sell |
47,700
-9,845
| -17% | -$1.25M | 0.02% | 235 |
|
|
2014
Q3 | $7.1M | Buy |
57,545
+8,900
| +18% | +$1.09M | 0.02% | 232 |
|
|
2014
Q2 | $5.84M | Sell |
48,645
-15,495
| -24% | -$1.73M | 0.02% | 246 |
|
|
2014
Q1 | $7.06M | Sell |
64,140
-41,374
| -39% | -$4.53M | 0.02% | 240 |
|
|
2013
Q4 | $12.1M | Buy |
105,514
+46,516
| +79% | +$4.8M | 0.03% | 195 |
|
|
2013
Q3 | $5.37M | Buy |
58,998
+5,900
| +11% | +$521K | 0.01% | 298 |
|
|
2013
Q2 | $4.29M | Buy |
+53,098
| New | +$4.13M | 0.01% | 327 |
|
Other funds holding AMP
VCM
VPM
N
Grantham, Mayo, Van Otterloo & Co (GMO)'s AMP Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Ameriprise Financial (AMP) stake by 0.42% in Q1 2026, buying an estimated $4.82K and bringing the position to 2,419 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #499.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AMP in Q2 2013 and has held it in 37 quarters since. The position peaked at $26.2M in Q4 2017. 1,383 funds tracked by Wall St. Rank hold AMP as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 2,419 shares of Ameriprise Financial worth $1.07M as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 10 Ameriprise Financial shares in Q1 2026, an estimated $4.82K.
- Ameriprise Financial made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #499 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Ameriprise Financial in Q2 2013 and has held it in 37 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Ameriprise Financial position peaked at $26.2M in Q4 2017.
- 1,383 funds tracked by Wall St. Rank held Ameriprise Financial as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.